Type 10 17β-hydroxysteroid dehydrogenase expression is regulated by C/EBPβ in HepG2 cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 4, 2010, Pages 164-171

  Rotinen, Mirja ^a   Villar, Joaquín ^a,b   Celay, Jon ^a   Encío, Ignacio ^a  

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

17 Hydroxysteroid dehydrogenases; C EBP ; Gene regulation; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN BETA1; CCAAT ENHANCER BINDING PROTEIN BETA10; CCAAT ENHANCER BINDING PROTEIN BETA11; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 10; UNCLASSIFIED DRUG; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; HSD17B10 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; BINDING SITE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; DNA FLANKING REGION; GENE CONTROL; GENE MUTATION; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HUMAN; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; TRANSCRIPTION INITIATION;

3-HYDROXYACYL COA DEHYDROGENASES; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTIONAL ACTIVATION;

MAMMALIA;

EID: 77957258218     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.07.003     Document Type: Article

References (32)

1. Prehn C., Moller G., Adamski J. Recent advances in 17beta-hydroxysteroid dehydrogenases. J. Steroid Biochem. Mol. Biol. 2009, 114(1-2):72-77.
2. Matsuura K., Shiraishi H., Hara A., Sato K., Deyashiki Y., Ninomiya M., Sakai S. Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J. Biochem. 1998, 124(5):940-946.
3. Moeller G., Adamski J. Integrated view on 17beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 2009, 301(1-2):7-19.
4. Huang X.F., Luu-The V. Molecular characterization of a first human 3 (alpha→beta)-hydroxysteroid epimerase. J. Biol. Chem. 2000, 275(38):29452-29457.
5. Akiyama T.E., Gonzalez F.J. Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochim. Biophys. Acta 2003, 1619(3):223-234.
6. Reed B.D., Charos A.E., Szekely A.M., Weissman S.M., Snyder M. Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet. 2008, 4(7):e1000133.
7. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic acids Res. 1998, 26(5):1135-1143.
8. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007, 17(7):318-324.
9. Descombes P., Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991, 67(3):569-579.
10. Zahnow C.A., Younes P., Laucirica R., Rosen J.M. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J. Natl. Cancer Inst. 1997, 89(24):1887-1891.
11. Cheng Y.H., Imir A., Suzuki T., Fenkci V., Yilmaz B., Sasano H., Bulun S.E. SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium. Biol. Reprod. 2006, 75(4):605-614.
12. Leenders F., Dolez V., Begue A., Moller G., Gloeckner J.C., de Launoit Y., Adamski J. Structure of the gene for the human 17beta-hydroxysteroid dehydrogenase type IV. Mamm. Genome 1998, 9(12):1036-1041.
13. Piao Y.S., Peltoketo H., Vihko P., Vihko R. The proximal promoter region of the gene encoding human 17beta-hydroxysteroid dehydrogenase type 1 contains GATA, AP-2, and Sp1 response elements: analysis of promoter function in choriocarcinoma cells. Endocrinology 1997, 138(8):3417-3425.
14. Peltoketo H., Piao Y., Mannermaa A., Ponder B.A., Isomaa V., Poutanen M., Winqvist R., Vihko R. A point mutation in the putative TATA box, detected in nondiseased individuals and patients with hereditary breast cancer, decreases promoter activity of the 17 beta-hydroxysteroid dehydrogenase type 1 gene 2 (EDH17B2) in vitro. Genomics 1994, 23(1):250-252.
15. Qin K., Rosenfield R.L. Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene. Biochim. Biophys. Acta 2005, 1728(3):115-125.
16. Ohnesorg T., Adamski J. Analysis of the 5′ flanking regions of human and murine HSD17B7: identification of a cholesterol dependent enhancer region. Mol. Cell. Endocrinol. 2006, 248(1-2):164-167.
17. Villar J., Celay J., Alonso M.M., Rotinen M., de Miguel C., Migliaccio M., Encio I. Transcriptional regulation of the human type 8 17beta-hydroxysteroid dehydrogenase gene by C/EBPbeta. J. Steroid Biochem. Mol. Biol. 2007, 105(1-5):131-139.
18. Nagasaki S., Miki Y., Akahira J., Suzuki T., Sasano H. Transcriptional regulation of 17beta-hydroxysteroid dehydrogenase type 12 by SREBP-1. Mol. Cell. Endocrinol. 2009, 307(1-2):163-168.
19. Ohnesorg T., Keller B., Hrabe de Angelis M., Adamski J. Transcriptional regulation of human and murine 17beta-hydroxysteroid dehydrogenase type-7 confers its participation in cholesterol biosynthesis. J. Mol. Endocrinol. 2006, 37(1):185-197.
20. Rotinen M., Celay J., Alonso M.M., Arrazola A., Encio I., Villar J. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta. J. Endocrinol. 2009, 200(1):85-92.
21. Ohnesorg T., Adamski J. Promoter analyses of human and mouse 17beta-hydroxysteroid dehydrogenase type 7. J. Steroid Biochem. Mol. Biol. 2005, 94(1-3):259-261.
22. Cassel T.N., Nord M. C/EBP transcription factors in the lung epithelium. Am. J. Physiol. 2003, 285(4):L773-L781.
23. Grimm S.L., Contreras A., Barcellos-Hoff M.H., Rosen J.M. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice. J. Biol. Chem. 2005, 280(43):36301-36309.
24. Pal R., Janz M., Galson D.L., Gries M., Li S., Johrens K., Anagnostopoulos I., Dorken B., Mapara M.Y., Borghesi L., Kardava L., Roodman G.D., Milcarek C., Lentzsch S. C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells. Blood 2009, 114(18):3890-3898.
25. Mantena S.R., Kannan A., Cheon Y.P., Li Q., Johnson P.F., Bagchi I.C., Bagchi M.K. C/EBPbeta is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(6):1870-1875.
26. Sai S., Esteves C.L., Kelly V., Michailidou Z., Anderson K., Coll A.P., Nakagawa Y., Ohzeki T., Seckl J.R., Chapman K.E. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta. Mol. Endocrinol. (Baltimore, MD) 2008, 22(9):2049-2060.
27. Seckl J.R. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr. Opin. Pharmacol. 2004, 4(6):597-602.
28. Yang S.Y., He X.Y., Schulz H. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Trends Endocrinol. Metab.: TEM 2005, 16(4):167-175.
29. Rauschenberger K., Scholer K., Sass J.O., Sauer S., Djuric Z., Rumig C., Wolf N.I., Okun J.G., Kolker S., Schwarz H., Fischer C., Grziwa B., Runz H., Numann A., Shafqat N., Kavanagh K.L., Hammerling G., Wanders R.J., Shield J.P., Wendel U., Stern D., Nawroth P., Hoffmann G.F., Bartram C.R., Arnold B., Bierhaus A., Oppermann U., Steinbeisser H., Zschocke J. A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival. EMBO Mol. Med. 2010, 2(2):51-62.
30. Jazbutyte V., Kehl F., Neyses L., Pelzer T. Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria. Biochem. Biophys. Res. Commun. 2009, 384(4):450-454.
31. He X.Y., Merz G., Chu C.H., Lin D., Yang Y.Z., Mehta P., Schulz H., Yang S.Y. Molecular cloning, modeling, and localization of rat type 10 17beta-hydroxysteroid dehydrogenase. Mol. Cell. Endocrinol. 2001, 171(1-2):89-98.
32. Brereton P., Suzuki T., Sasano H., Li K., Duarte C., Obeyesekere V., Haeseleer F., Palczewski K., Smith I., Komesaroff P., Krozowski Z. Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. Mol. Cell. Endocrinol. 2001, 171(1-2):111-117.